~18 spots leftby Aug 2025

Wellness Intervention for Smoking Cessation in Veterans with HIV

(WISH Trial)

Recruiting in Palo Alto (17 mi)
+1 other location
KC
Overseen byKristina A Crothers, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Seattle Institute for Biomedical and Clinical Research
No Placebo Group

Trial Summary

What is the purpose of this trial?

This project will compare the effectiveness of an HIV-specific comprehensive wellness intervention designed to have broad appeal to smokers living with HIV to the effectiveness of standard care services that include referral to the National VA Quitline and SmokefreeVET texting program. Participants in both arms will have access to pharmacotherapy available through their Veterans Affairs (VA) healthcare providers.

Research Team

KC

Kristina A Crothers, MD

Principal Investigator

VA Puget Sound Health Care System

Eligibility Criteria

This trial is for veterans living with HIV who smoke at least 5 cigarettes a day, are in VA care, can text, and speak English. It's not for those with hearing/comprehension issues, institutionalized individuals, people with severe cognitive impairments, pregnant women or anyone already getting help to quit smoking.

Inclusion Criteria

I am HIV positive.
English speaking
In care in the VA
See 2 more

Exclusion Criteria

You are currently pregnant.
I am currently trying to quit smoking with counseling or FDA-approved treatments.
You have a history of severe mental illness, memory problems, or difficulty thinking clearly.
See 2 more

Treatment Details

Interventions

  • Wellness Intervention for Smokers with HIV (Behavioral Intervention)
Trial OverviewThe study compares a wellness intervention tailored for smokers with HIV against standard services like the National VA Quitline and SmokefreeVET texting. Participants also have access to quitting medications through their VA healthcare providers.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention - Wellness Intervention for Smokers with HIVExperimental Treatment1 Intervention
The experimental WISH intervention is an HIV-specific comprehensive wellness program designed to offer integrated phone and text counseling regardless of readiness to quit.
Group II: Control - Standard CareActive Control1 Intervention
The control intervention is referral to standard evidence-based cessation services available nationally to Veterans, including the National VA Quitline and SmokefreeVET texting program.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Seattle Institute for Biomedical and Clinical Research

Lead Sponsor

Trials
55
Recruited
13,700+

Kaiser Permanente

Collaborator

Trials
563
Recruited
27,400,000+
Greg A. Adams profile image

Greg A. Adams

Kaiser Permanente

Chief Executive Officer since 2019

MBA from University of Southern California

Dr. Edward M. Ellison profile image

Dr. Edward M. Ellison

Kaiser Permanente

Chief Medical Officer since 2015

MD from Harvard Medical School

University of California, Davis

Collaborator

Trials
958
Recruited
4,816,000+
Rakesh Dixit profile image

Rakesh Dixit

University of California, Davis

Chief Executive Officer since 2024

PhD in Biochemistry and Molecular Biology from the University of California, Davis

Suresh Mahabhashyam profile image

Suresh Mahabhashyam

University of California, Davis

Chief Medical Officer since 2020

MD from Bangalore Medical College

Yale University

Collaborator

Trials
1,963
Recruited
3,046,000+
Nancy J. Brown profile image

Nancy J. Brown

Yale University

Chief Medical Officer since 2020

MD from Yale School of Medicine

Peter Salovey profile image

Peter Salovey

Yale University

Chief Executive Officer since 2013

PhD in Psychology from Yale University

Fred Hutchinson Cancer Center

Collaborator

Trials
583
Recruited
1,341,000+
Dr. W. Thomas Purcell profile image

Dr. W. Thomas Purcell

Fred Hutchinson Cancer Center

Chief Medical Officer since 2022

MD from Emory University School of Medicine, MBA from University of Chicago

Dr. Thomas J. Lynch Jr. profile image

Dr. Thomas J. Lynch Jr.

Fred Hutchinson Cancer Center

Chief Executive Officer since 2020

MD from Yale School of Medicine

US Department of Veterans Affairs

Collaborator

Trials
881
Recruited
502,000+
Kameron Leigh Matthews profile image

Kameron Leigh Matthews

US Department of Veterans Affairs

Chief Medical Officer since 2021

MD from Johns Hopkins University

Doug Collins profile image

Doug Collins

US Department of Veterans Affairs

Secretary of Veterans Affairs

BA in Political Science from North Georgia College & State University